FIELD: medicine, hematology, homeopathy, pharmacy. SUBSTANCE: invention relates to the developed antibody-base medicinal agent that comprises activated form of supersmall doses of monoclonal, polyclonal or natural antibodies raised to erythropoietin prepared by multiple successive dilution and external effect, mainly by homeopathic technology. For preparing antibodies human or heterogeneous alpha-, beta- or omega-erythropoietin, among them, recombinant or genetic engineering one is used being mixture of different, mainly, hundredth dilutions is used. Invention can be used for treatment and prophylaxis of acute and chronic diseases associated with hemopoiesis impairment, mainly, erythropoiesis. EFFECT: expanded arsenal of homeopathic agents. 4 cl, 1 tbl, 3 ex
